Hugh Neuharth

Hugh Neuharth brings more than 30 years of senior finance and operating experience with startup through multinational life sciences companies. 

Prior to joining Mavrik Dental Systems, Neuharth served as chief financial officer at Fjord Ventures LLC since its inception; he also served in this capacity for all of Fjord’s portfolio companies through the early stages of their development, including Adagio Medical Inc., Anaxiom Corporation, Kato Pharmaceuticals Inc., Metronom Health Inc., Prelude Corporation, Sonendo Inc. (NYSE: SONX) and YAP Therapeutics Inc. 

Neuharth also served as chief financial officer of BioLucent Inc. (acquired by Hologic Inc.), Cianna Medical Inc. (acquired by Merit Medical Systems Inc.) and Glaukos Corporation (NASDAQ: GKOS).

Previously, Neuharth spent more than a decade with Smith & Nephew PLC (LSE: SN), an FTSE 100 global medical technology firm, most recently as a regional board director and the senior operations and finance executive in charge of the company’s businesses in the Australasia region headquartered in Melbourne, Australia.